|
Bieżący numer
Archiwum
Filmy
Artykuły w druku
O czasopiśmie
Suplementy
Rada naukowa
Recenzenci
Bazy indeksacyjne
Prenumerata
Kontakt
Zasady publikacji prac
Opłaty publikacyjne
Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
|
1/2023
vol. 125 streszczenie artykułu:
Opis przypadku
Valsalva retinopathy – a patient with a Leiden mutation in the coagulation factor V gene and increased blood clotting
Aleksander Lamkowski
1
,
Martyna Kałużna
1
,
Tomasz Pabin
1
KLINIKA OCZNA 2023, 125, 1: 56-59
Data publikacji online: 2023/02/09
Pełna treść artykułu
Pobierz cytowanie
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Valsalva retinopathy is a rare disease in which the pressure in the eye increases, leading to the development of a pre-retinal hemorrhage. It frequently occurs in completely healthy patients and leads to sudden and painless vision loss. It may arise due to vomiting, coughing, constipation, pregnancy, childbirth, and intense physical or sexual activity. In this article, we describe the case of a young man who developed Valsalva retinopathy. The development and progression of nuclear cataracts may be influenced by many factors such as the process of lens oxidation, the use of infusion fluids, light toxicity, duration of vitrectomy or the type of endotamponade. The key to preventing cataract formation after vitrectomy is still elusive. |
ENGLISH
